Stock Market Reviews

VANI (Vivani Medical, Inc.) News

Get the latest news, insights, and market updates on VANI (Vivani Medical, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Vivani Medical: Q3 Earnings Snapshot
  ALAMEDA, Calif. AP) — Vivani Medical, Inc. VANI) on Thursday reported a loss of $6.5 million in its third quarter.
  Nov 13, 2025 - $VANI
• Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results
  Company plans to initiate Phase 1 clinical study of semaglutide implant for chronic weight management in the first half of 2026 and parallel investments in studies to enable rapid initiation of Phase 2 dose-ranging study, pending Phase 1 results and regulatory feedback 3Q 2025 private placement, together with October financings, generated approximately $25.7M in cash and cash commitments to support accelerated development of NPM-139 while securing financial position into 2027 ALAMEDA, Calif., No
  Nov 13, 2025 - $VANI
• Vivani Medical, Inc. Announces Closing of Common Stock Offering
  ALAMEDA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the closing of its previously announced best efforts registered direct offering of 6,000,000 shares of its common stock at an offering price of $1.62 per share and a concurrent private placement of 3,703,703 shares of its common stock at an offering price of $1.62 per s
  Oct 28, 2025 - $VANI
• Insiders Are Buying These 3 Stocks Hand Over Fist
  Insider buys can be a telltale sign of a turnaround, as these investments give you a window into where management stands with a company. Studies have shown that insider buys often lead to the stock performing well. It’s easy to understand why, as no one wants to throw money at a sinking ship, even if ... Insiders Are Buying These 3 Stocks Hand Over Fist
  Oct 28, 2025 - $VANI
• Vivani Medical, Inc. Announces Pricing of Common Stock Offering
  ALAMEDA, Calif., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the pricing of a best efforts registered direct offering of 6,000,000 shares of its common stock at an offering price of $1.62 per share and concurrent private placement of 3,703,703 shares of its common stock at an offering price of $1.62 per share purchased by Gregg W
  Oct 26, 2025 - $VANI
• Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025
  ALAMEDA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced that Chief Executive Officer Adam Mendelsohn, Ph.D., will provide a Company Presentation at the ThinkEquity Conference on October 30, 2025 in New York. Event details are as follows:Presentation Date: Thursday, October 30, 2025Presentation Time: 1:30 p.m. Eastern TimeLoc
  Oct 22, 2025 - $VANI
• 3 Promising Penny Stocks With Market Caps Under $900M
  As the U.S. markets close higher after a volatile week, investors are keenly observing opportunities that might arise amidst fluctuating conditions and economic uncertainties. Penny stocks, often seen as relics of speculative trading, still hold potential when underpinned by solid financials and growth prospects. In this article, we explore three penny stocks that exemplify strong balance sheets and promising fundamentals, offering investors a chance to uncover hidden value in companies with...
  Oct 20, 2025 - $VANI
• Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off
  The Company expects to reestablish and announce a new record date as soon as possibleALAMEDA, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced that the Company will temporarily withdraw the previously announced record date for the planned spin-off of Cortigent, Inc. (“Cortigent”), its wholly-owned subsidiary developing brain i
  Oct 3, 2025 - $VANI
• Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025
  ALAMEDA, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced that it will present at the Emerging Growth Conference 86 on September 25, 2025. Vivani welcomes individual and institutional investors, along with advisors and analysts, to join its interactive presentation. This live online event will offer existing shareholders and
  Sep 24, 2025 - $VANI
• Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream
  MIAMI, Sept. 24, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting c
  Sep 24, 2025 - $VANI